During the past decade, Neurological Associates of Albany, PC conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 9 clinical trials were completed, i.e. on average, 39.1% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 6 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurological Associates of Albany, PC" #1 sponsor was "Eisai Inc." with 4 trials, followed by "TauRx Therapeutics Ltd" with 4 trials sponsored, "Athira Pharma" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Neurotrope Bioscience, Inc." with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurological Associates of Albany, PC" #1 collaborator was "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Alzheimer's Association" with 2 trials as a collaborator, "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Neurological Associates of Albany, PC" are "Alzheimer Disease" (16 trials), "Alzheimer's Disease" (13 trials), "Dementia of Alzheimer Type" (2 trials), "Early Alzheimer's Disease" (2 trials) and "Major Depressive Disorder" (2 trials). Many other conditions were trialed in "Neurological Associates of Albany, PC" in a lesser frequency.

Most popular intervention types in "Neurological Associates of Albany, PC" are "Drug" (40 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "ATH-1017" (3 trials), "Bryostatin 1" (2 trials), "Donanemab" (2 trials) and "Placebo Control" (2 trials). Other intervention names were less common.

The vast majority of trials in "Neurological Associates of Albany, PC" are 40 trials for "All" genders.

Currently, there are NaN active trials in "Neurological Associates of Albany, PC". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Neurological Associates of Albany, PC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Neurological Associates of Albany, PC, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".